Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Pin to quick picksAMYT.L Share News (AMYT)

  • There is currently no data for AMYT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director dealings: Amryt Pharma chairman makes share purchase

Mon, 15th Mar 2021 16:38

(Sharecast News) - Amryt Pharma revealed on Monday that chairman Ram Stafford had acquired 300,100 ordinary shares in the AIM-listed commercial-stage biopharmaceutical company.
Stafford, who previously headed up Sudocrem owner Tosara Group, purchased the shares on Friday at an average price of 200.0p per share, for a total value of £600,200.

Last week, Amryt announced the signing of a distribution agreement with Medison Pharma to distribute its Myalepta product in Canada.

Amryt said the agreement completed its multi-regional distribution deals with Medison, first announced in February, to distribute Myalepta and Lojuxta in Israel and Juxtapid in Canada.

As of 1645 GMT, Amryt shares were up 3.54% at 205.0p.

Top Director Buys

Amryt Pharma (AMYT)
Director name: Stafford,Ray
Amount purchased: 300,100 @ 200.00p
Value: £600,200.00

Newriver Reit (NRR)
Director name: Lockhart,Allan
Amount purchased: 224,489 @ 97.58p
Value: £219,056.36

Newriver Reit (NRR)
Director name: Davies,Mark
Amount purchased: 185,000 @ 96.20p
Value: £177,970.00

Photo-me International (PHTM)
Director name: Crasnianski,Serge
Amount purchased: 282,029 @ 51.11p
Value: £144,145.02

Photo-me International (PHTM)
Director name: Crasnianski,Serge
Amount purchased: 250,000 @ 51.35p
Value: £128,374.99

Edinburgh Worldwide Inv Trust (EWI)
Director name: Wilson,Mungo
Amount purchased: 35,613 @ 350.50p
Value: £124,823.57

W Resources (WRES)
Director name: Masterman,Michael
Amount purchased: 95,000,000 @ 0.09p
Value: £86,402.50

Serco Group (SRP)
Director name: Lodge,Tim
Amount purchased: 40,000 @ 127.20p
Value: £50,880.00

Frenkel Topping Group (FEN)
Director name: Mills,Christopher
Amount purchased: 100,000 @ 45.00p
Value: £45,000.00

W Resources (WRES)
Director name: Masterman,Michael
Amount purchased: 37,000,000 @ 0.09p
Value: £31,524.00

F&c Investment Trust (FCIT)
Director name: Joy,Tom
Amount purchased: 3,500 @ 788.86p
Value: £27,610.10

W Resources (WRES)
Director name: Masterman,Michael
Amount purchased: 18,000,000 @ 0.09p
Value: £16,830.00

Lxi Reit (LXI)
Director name: Dimond,Patricia
Amount purchased: 8,005 @ 124.92p
Value: £9,999.53

Rockfire Resources (ROCK)
Director name: Walley,Nicholas
Amount purchased: 536,000 @ 0.95p
Value: £5,092.00

F&c Investment Trust (FCIT)
Director name: Ecsery,Francesca
Amount purchased: 380 @ 783.48p
Value: £2,977.24



Top Director Sells

Pagegroup (PAGE)
Director name: Ingham,Stephen
Amount sold: 41,638 @ 480.10p
Value: £199,904.04

Newriver Reit (NRR)
Director name: Davies,Mark
Amount sold: 185,000 @ 96.20p
Value: £177,970.00

Dukemount Capital (DKE)
Director name: Dart,Geoffrey
Amount sold: 27,000,000 @ 0.60p
Value: £162,000.00

Newriver Reit (NRR)
Director name: Lockhart,Allan
Amount sold: 133,745 @ 97.20p
Value: £130,000.14

Pagegroup (PAGE)
Director name: Stagg ,Kelvin
Amount sold: 20,774 @ 480.10p
Value: £99,735.98

Cropper (james) (CRPR)
Director name: Maddock,Isabelle
Amount sold: 500 @ 1,100.00p
Value: £5,500.00

More News
9 Dec 2020 09:47

Amryt Pharma gets approval for 'Lojuxta' in Brazil

(Sharecast News) - Biopharmaceutical company Amryt Pharma announced on Wednesday that it has received marketing authorisation approval from the Brazilian Health Regulatory Agency (ANVISA) for 'Lojuxta', or lomitapide.

Read more
8 Dec 2020 09:22

Amryt Pharma raising $40m for working capital, acquisitions

(Sharecast News) - Commercial-stage biopharmaceutical company Amryt Pharma has entered into agreements to raise $40m, it announced on Tuesday, to fund working capital as well as potential acquisitions and licence deals.

Read more
29 Oct 2020 19:11

IN BRIEF: Amryt Pharma Posts Success From Filsuvez Trial

IN BRIEF: Amryt Pharma Posts Success From Filsuvez Trial

Read more
29 Oct 2020 16:09

Amryt shares rise on success of 'EASE' trial

(Sharecast News) - Biopharmaceutical company Amryt Pharma announced positive results from its pivotal phase 23 'EASE' trial of 'Filsuvez', or 'Oleogel-S10', previously 'AP101', on Thursday.

Read more
29 Oct 2020 16:02

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
19 Oct 2020 15:43

IN BRIEF: Amryt Pharma Signs Distribution Deal With Swixx Biopharma

IN BRIEF: Amryt Pharma Signs Distribution Deal With Swixx Biopharma

Read more
19 Oct 2020 08:34

Amryt Pharma signs new distribution deal with Swixx BioPharma

(Sharecast News) - Commercial-stage biopharmaceutical company Amryt Pharma announced the signing of a distribution agreement with Swixx BioPharma of Baar, Switzerland on Monday.

Read more
15 Sep 2020 22:08

UK TRADING UPDATE SUMMARY: Mortgage Advice Bureau Launches Later Life

UK TRADING UPDATE SUMMARY: Mortgage Advice Bureau Launches Later Life

Read more
9 Sep 2020 13:26

Amryt shares surge on Filsuvez phase 3 results

(Sharecast News) - Commercial-stage biopharmaceutical company Amryt Pharma announced positive top-line results from its pivotal phase 3 'EASE' trial of 'Filsuvez' for the treatment of dystrophic and junctional epidermolysis bullosa on Wednesday.

Read more
9 Sep 2020 10:50

UK WINNERS & LOSERS SUMMARY: Amryt Surges Nearly 50% On Trial Results

UK WINNERS & LOSERS SUMMARY: Amryt Surges Nearly 50% On Trial Results

Read more
9 Sep 2020 10:31

Amryt Pharma Shares Jump On Positive Third-Phase Filsuvez Trial Result

Amryt Pharma Shares Jump On Positive Third-Phase Filsuvez Trial Result

Read more
8 Jul 2020 17:13

IN BRIEF: Amryt Lauds Nasdaq Global Listing "Milestone"

IN BRIEF: Amryt Lauds Nasdaq Global Listing "Milestone"

Read more
24 Jun 2020 14:12

IN BRIEF: Amryt Pharma To List American Depository Shares In US

IN BRIEF: Amryt Pharma To List American Depository Shares In US

Read more
4 Jun 2020 14:58

UK DIRECTOR DEALINGS SUMMARY: XP Power Chair In GBP3.6 Million Sale

UK DIRECTOR DEALINGS SUMMARY: XP Power Chair In GBP3.6 Million Sale

Read more
3 Jun 2020 16:23

UK DIRECTOR DEALINGS SUMMARY: Braveheart Investment CEO Cuts Stake

UK DIRECTOR DEALINGS SUMMARY: Braveheart Investment CEO Cuts Stake

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.